A research team has discovered that the two key pathological hallmarks of Alzheimer's -- tau protein and beta-amyloid -- affect brain circuits in distinct yet synergistic ways, particularly those ...

New research has shown that diet could influence the risk of both depression and Alzheimer's disease (AD). Evidence suggests that depressive symptoms are both a risk factor for AD and a reaction to ...

Life isn’t always sunshine and rainbows. While some days feel like a breeze, other days are chaos. That’s where a little positivity makes all the difference. We’ve curated more than 85 positive ...

Happiness is about embracing the good times and making the most of every moment. But we all know for a fact that happiness is ...

Last month, the European Medicines Agency allowed Novo to add risk reduction for events related to kidney disease to the ...

Today, the Susan and Charles Berghoff Foundation announced the public release of its award-winning documentary film, Sue's ...

BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's Supplemental Biologics License Application ...

“Readers say this book is full of inspirational quotes to savor during the tough days and packed with lessons on how to become your most authentic self,” Skyvara highlights. “It’s ...

Safety, tolerability, pharmacokinetic, and pharmacodynamic profile supports continued development of VG-3927 as potential once-daily oral therapy for Alzheimer’s disease (AD) - - Robust and dose ...

The Watertown, Massachusetts-based biotechnology firm announced the positive outcome on January ... the AD/PD™ 2025 International Conference on Alzheimer’s and Parkinson’s Disease.

“We are very excited by these positive Phase 1 data ... oral presentation at the AD/PDTM 2025 International Conference on Alzheimer's and Parkinson's Disease taking place April 1-5, 2025 ...